The use of the AS1411aptamer confers these nanoparticles high tumor specificity, given that this aptamer binds specifically to nucleolin, which is a protein over-expressed on the cell surface of many types of tumor, including CRC (191). Here, NUCLEOLIN is linked to neoplasm.